No clinical guidelines for surveillance are available.

The following evaluations are suggested, with frequency varying according to the severity of the condition:

Liver function tests including liver transaminases (ALT and AST), GGT, albumin, total and direct bilirubin, and coagulation profile (PT and PTT)

Hepatic ultrasound examination to screen for liver masses that might suggest HCC

Serum alpha fetoprotein (AFP) concentration

Developmental evaluation

Neurologic assessment

Nutritional assessment

Urinalysis and urine amino acids to assess for renal tubulopathy

Ophthalmologic examination
